Access the full text.
Sign up today, get DeepDyve free for 14 days.
Rowena Forsyth, Camilla Scanlan, S. Carter, C. Jordens, I. Kerridge (2011)
Decision Making in a Crowded RoomQualitative Health Research, 21
K. Watson (2014)
A piece of my mind. Reframing regret.JAMA, 311 1
S. Halpern, G. Loewenstein, K. Volpp, Elizabeth Cooney, K. Vranas, C. Quill, M. McKenzie, M. Harhay, Nicole Gabler, Tatiana Silva, R. Arnold, D. Angus, C. Bryce (2013)
Default options in advance directives influence how patients set goals for end-of-life care.Health affairs, 32 2
H. Beecher (1966)
Ethics and clinical research.The New England journal of medicine, 274 24
N. Grulke, H. Bailer (2010)
Facing haematopoietic stem‐cell transplantation: do patients and their physicians agree regarding the prognosis?Psycho‐Oncology, 19
D. Kahneman (2011)
Thinking, Fast and Slow
L. Jacoby, B. Maloy, E. Cirenza, W. Shelton, T. Goggins, J. Balint (1999)
The basis of informed consent for BMT patientsBone Marrow Transplantation, 23
D. Kahneman, A. Tversky (1979)
Prospect theory: An analysis of decision under risk Econometrica 47
D. Kahneman, A. Tversky (1979)
PROSPECT THEORY: AN ANALYSIS OF DECISION UNDER RISKEconometrica, 47
Lisa Rosenbaum (2015)
The Paternalism Preference--Choosing Unshared Decision Making.The New England journal of medicine, 373 7
A. Gratwohl (1998)
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantationThe Lancet, 352
E. Peters, J. Hibbard, P. Slovic, N. Dieckmann (2007)
Numeracy skill and the communication, comprehension, and use of risk-benefit information.Health affairs, 26 3
K Watson (2014)
Reframing regretJAMA, 311
Anita D'Souza, M. Pasquini, R. Spellecy (2015)
Is ‘informed consent’ an ‘understood consent’ in hematopoietic cell transplantation?Bone Marrow Transplantation, 50
R. Thaler, C. Sunstein (2008)
Nudge: Improving Decisions About Health, Wealth, and Happiness
T. Parimon, D. Au, P. Martin, J. Chien (2006)
A Risk Score for Mortality after Allogeneic Hematopoietic Cell TransplantationAnnals of Internal Medicine, 144
M. Sorror, M. Maris, R. Storb, F. Baron, B. Sandmaier, D. Maloney, B. Storer (2005)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.Blood, 106 8
B. McNeil, S. Pauker, H. Sox, A. Tversky (1982)
On the elicitation of preferences for alternative therapies.The New England journal of medicine, 306 21
J. Pidala, Benjamin Craig, S. Lee, N. Majhail, G. Quinn, C. Anasetti (2012)
Practice variation in physician referral for allogeneic hematopoietic cell transplantationBone Marrow Transplantation, 48
I. Lipkus, G. Samsa, B. Rimer (2001)
General Performance on a Numeracy Scale among Highly Educated SamplesMedical Decision Making, 21
A Gratwohl, J Hermans, JM Goldman (1998)
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationLancet, 352
J. Duffy, F. Boland (2009)
The First Anesthetic: The Story of Crawford Long
Angela Smith, E. Warlick, M. Roesler, J. Poynter, Michaela Richardson, P. Nguyen, A. Cioc, B. Hirsch, J. Ross (2015)
Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in MinnesotaAnnals of Hematology, 94
Alastair Baker (2001)
Crossing the Quality Chasm: A New Health System for the 21st CenturyBMJ : British Medical Journal, 323
J. Payne, J. Bettman, Eric Johnson (1992)
Behavioral decision research: A constructive processing perspective.Annual Review of Psychology, 43
Stephanie Lee, D. Fairclough, J. Antin, J. Weeks (2001)
Discrepancies between patient and physician estimates for the success of stem cell transplantation.JAMA, 285 8
M. Schwarze, A. Redmann, G. Alexander, K. Brasel (2013)
Surgeons Expect Patients to Buy-In to Postoperative Life Support Preoperatively: Results of a National Survey*Critical Care Medicine, 41
S. Servais, R. Porcher, A. Xhaard, M. Robin, E. Masson, J. Larghero, P. Ribaud, N. Dhedin, Sarah Abbes, Flore Sicre, G. Socié, R. Latour (2014)
Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donorsHaematologica, 99
Informed consent is the process by which a competent patient is provided with a sufficient amount of relevant information to make an educated decision about a procedure. The process of informed consent is designed to prioritize patients’ autonomy. Stem cell transplant (SCT) is a complicated process with many possible results and requirements for on-going decision-making depending on outcomes and complications. While understanding basic theories of decision science will help the physician provide improved information at the time of consent, experiential learning by the patients as they proceed through SCT may have the strongest influence in continued patient decision-making that may or may not align with their initial informed consent.
Current Hematologic Malignancy Reports – Springer Journals
Published: Feb 2, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.